CC Diagnostics aims to market a superior method for diagnosing early stages of cervical cancer. With this accurate test implemented in national cervical cancer screening programs (or sold on the private market), a big part of unneeded follow-up diagnostic can be prevented. As a result, healthcare costs and women’s stress will be reduced. With this method of testing, CC Diagnostics can play its part in making sure there is accurate and participative cervical screening available for every woman.
| Website | http://www.cc-diagnostics.com |
| Employees | 7 (5 on RocketReach) |
| Founded | 2016 |
| Technologies |
JavaScript
,
HTML
,
PHP
+8 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Cervical Cancer Screening, Cancer Screening Test, Cancer Diagnostics, Oncology Diagnostics, Hpv Testing, Medical Diagnostics, Healthcare Diagnostics, In Vitro Diagnostics, Molecular Diagnostics, Medical Testing, Diagnostic Tests, Womens Health, Cancer Detection |
| Competitors | Roche, Thermo Fisher Scientific, Mayo Clinic Laboratories, Quest Diagnostics, Labcorp, PerkinElmer, Inc., BioReference Laboratories, ARUP Laboratories, Invitae, Genomic Health +33 more (view full list) |
Looking for a particular CC Diagnostics employee's phone or email?
Jolien de Waard is the Chief Scientific Officer of CC Diagnostics.
5 people are employed at CC Diagnostics.
CC Diagnostics is based in Groningen, Groningen.